GL1X · GenesisL1 explorer

MolNFT v1 · #160858 · protein

Cystal structure of myotoxin II from bothrops moojeni co-crystallized with varespladib (LY315920)

6PWH · Basic phospholipase A2 homolog 2: “Cystal structure of myotoxin II from bothrops moojeni co-crystallized with varespladib (LY315920)”. X-ray diffraction, 1 ligand (VRD), 2 pockets (best druggability 0.66). MolNFT v1 #160858 on…

PDB
6PWH
Type
protein
Length
244 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Basic phospholipase A2 homolog 2
UniProt
Q9I834
Ligands
VRD
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 8% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBasic phospholipase A2 homolog 2protein12248% helix, 8% strandQ9I834

Ligands and binding sites

  • VRD · ({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid · ligand · 2 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12400.660.8326VRD
22490.650.8231VRD

Interfaces

1 interface between chains.

  • A–B · 682 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 14 disulfide (disulfide).

Compared structures

  • 6PWH · Cystal structure of Myotoxin II from Bothrops moojeni co-crystallized with Varespladib… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9I834 · AlphaFold monomer V2.0 prediction for basic phospholipase A2 homolog myotoxin II (Q9I834) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.